SOPHiA GENETICS (SOPH) Cash from Operations (2020 - 2026)

SOPHiA GENETICS has disclosed Cash from Operations across 7 years of filings, most recently posting -$7.7 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 5.4% year-over-year to -$7.7 million; the TTM figure through Jun 2026 stood at -$39.6 million (down 4.99% YoY), while the FY2025 annual figure was -$35.7 million, up 18.84% from the prior year.
• Cash from Operations came in at -$7.7 million for Q2 2026 at SOPHiA GENETICS, up from -$15.1 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of -$7.7 million in Q2 2026 to a low of -$23.1 million in Q3 2022.
• Average Cash from Operations over 5 years is -$12.6 million, with a median of -$11.0 million recorded in 2022.
• Year-over-year, Cash from Operations tumbled 71.39% in 2022 and soared 44.04% in 2023.
• Over 5 years, Cash from Operations stood at -$11.0 million in 2022, then declined by 14.4% to -$12.6 million in 2023, then rose by 16.15% to -$10.5 million in 2024, then rose by 22.64% to -$8.1 million in 2025, then grew by 5.72% to -$7.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$7.7 million in Q2 2026, -$15.1 million in Q1 2026, and -$8.1 million in Q4 2025.